Omnicell reported second-quarter 2026 revenue of US$312.21 million and net income of US$24.29 million, swinging to a profit in the first half of the year. The company raised its full-year 2026 revenue guidance to a range of US$1.23 billion to US$1.25 billion and projected third-quarter 2026 revenue of US$301 million to US$307 million. Both basic and diluted earnings per share from continuing operations rose compared with a year earlier. The improved profitability and higher guidance support the near-term catalyst of expanding margins, though risks from tariffs, cost inflation, and pressured hospital budgets remain.
Omnicell IncOmnicell raised 2026 revenue guidance and returned to profitability, boosting earnings outlook.